ALDEYRA THERAPEUTICS INC (ALDX:NASDAQ)
$1.68 -0.1 (-5.618%)
Analysed ALDEYRA THERAPEUTICS INC (ALDX:NASDAQ) News Sources
3 Stocks That May Be Undervalued By Up To 48.1% According To Intrinsic Value Estimates
10-04-2026
yahoo.com
3 Stocks Possibly Undervalued By Up To 47% Offering Potential Value
10-04-2026
yahoo.com
3 Stocks That May Be Trading Below Their Estimated Intrinsic Value
09-04-2026
yahoo.com
3 Stocks That May Be Undervalued In April 2026
09-04-2026
yahoo.com
Aldeyra Therapeutics And 2 More Promising Penny Stocks For Your Watchlist
25-03-2026
yahoo.com
ALDX Crashes 71% as FDA Issues Third CRL for Dry Eye Disease Drug NDA
18-03-2026
yahoo.com
Aspen’s fresh Parkinson’s data; Aldeyra tanks following FDA rejection
18-03-2026
biopharmadive.com
FDA issues CRL to Aldeyra’s reproxalap drug application
18-03-2026
hospitalmanagement.net
Aldeyra Therapeutics Shares Fall Pre-Bell After US FDA Response Cites Lack of Efficacy Data for Dry Eye Drug
17-03-2026
yahoo.com
Aldeyra Therapeutics Receives Complete Response Letter from the U.S. Food and Drug Administration for the Reproxalap New Drug Application for the Treatment of Signs and Symptoms of Dry Eye Disease
17-03-2026
yahoo.com
What is the current price of ALDEYRA THERAPEUTICS INC (ALDX:NASDAQ)?
The current price of ALDEYRA THERAPEUTICS INC (ALDX:NASDAQ) is $1.68.
ALDEYRA THERAPEUTICS INC (ALDX:NASDAQ) absolute price change since previous trading day?
The absolute price change of ALDEYRA THERAPEUTICS INC (ALDX:NASDAQ) since the previous trading day is $-0.1.
ALDEYRA THERAPEUTICS INC (ALDX:NASDAQ) percentage price change since previous trading day?
The percentage price change of ALDEYRA THERAPEUTICS INC (ALDX:NASDAQ) since the previous trading day is -5.618%.
What is the most recent average sentiment score for ALDEYRA THERAPEUTICS INC (ALDX:NASDAQ)?
The most recent average sentiment score for ALDEYRA THERAPEUTICS INC (ALDX:NASDAQ) is 72 out of 100.
What is the most recent average sentiment for ALDEYRA THERAPEUTICS INC (ALDX:NASDAQ)?
The most recent sentiment for ALDEYRA THERAPEUTICS INC (ALDX:NASDAQ) is .
SEC-8K** Filing Available For ALDEYRA THERAPEUTICS INC (ALDX:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.